Epix Achieves Milestone in Collaboration With GSK

Epix Pharmaceuticals has achieved a key milestone related to the second of three discovery programs under its collaboration with GlaxoSmithKline (GSK).

The company has identified three lead candidates to move into the second G-protein coupled receptor discovery program. Under the collaboration, Epix is entitled to receive a $3 million milestone payment from GSK in the next 30 days, Epix said.

In August, Epix announced it had identified three lead candidates for the first discovery program, which entitled the company to a $3 million milestone payment.